Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My TDA shows +27.39% with close at .06
DDDDDDDDD FFFFFFFFFFF!
Trying? I will say—again: we MUST have a tsunami of volume stemming directly from seismic news and numbers in order to have ANY hope of changing this pattern. Yesterday I used the words “immense” and “ineluctable,” as I recall. I was right then (negative reactions at the time notwithstanding) and I am right now. CELZ
Question: has CELZ ever had an intraday or EOD at +45%?
If past is any prediction, we’ll be lucky to see .065 before the 10-Q in mid-August. Just too many abortive false-start booms. And we all KNOW the basis for it is there—and yet they say nothing. And so we wait
The market DEMANDS some substantial communications activities SOON. Sadly we have lost committed longs who invested considerable time and energy in making this board the rare gem that it is! They, naturally given the OTC context, are looking to get maximum returns in minimal time—and that led them (at least in part) to diversify and place some money elsewhere. This is not a validation OR a condemnation of that decision—it is the reality we face here in the OTC dregs. Those companies who propel themselves OUT AND UP as quickly as possible do EVERYONE with a vested interest in them IMMEASURABLE good.
Unfortunately the market (which, like nature, abhors a vacuum) appears to be punishing CELZ for not filling the void well enough with news that will propel us into the dime range and SHED a good number of flippers.
It is within the power of management to change that fact, but for whatever reason they are resisting it. Unfortunately the market (which, like nature, abhors a vacuum) appears to be punishing CELZ for not filling the void well enough.
And volume is moderate to lowish
They’re trying to kill it!
My only regret is that I didn’t discover CELZ before February!
My bad—I hadn’t realized that the post was from another “ today”. Lol
Apologies for having to ask, but how can you tell that “11M shares bought at .05+ today,” when royal volume for the day (bought and sold) shows 9.85M shares?
And Gershman has been talking about 90% effectiveness for weeks now—which must be the essence of what the data will show once announced
HELL no! I’m just saying that this fairly moderate volume is allowing MMs to block and play games. Time to BLAST them outta the way with massive volume.
Who is “he”?
It’s gonna take massive, ineluctable volume to blast through.
Medistem, Gershman, Ichim, patents: nuff said.
Sooner or later they will concede: resistance is FUTILE!
The float is LOCKED and getting MORE locked with each passing hour. Therefore the basic laws of economics will soon overwhelm them...
Save that downhill walk for the dog!
Be not shaken—or stirred! CELZ STRONG.
Shares LOCKED GTC @$20. Bring it!
Ahhhh—the beauty of a LOCKED FLOAT!
Agree with what I think you’re saying, doc: the longs here tend to be very analytical and extremely conservative in their analytical estimates—and STILL come up with numbers that boggle the mind.
Even $10 PPS would be AMAZING.
Can anyone link Warbington’s statement about creating a money engine vs. selling in BO?
I went to HS with the man behind Prevacus (on the main webpage of this site). Lol
Is CELZ currently considering entering “Asia proper”—i.e. China, India, etc, or just Russia?
Roughly from where to where on POS?
.05-$1? Etc
What did those rise to and over what period of time (roughly)?
Think that’s one of the reasons they spilt off?
To wit, check out the Twitter feeds of: Dr. Gershman, Dr. Said, SeatonBM, and SOG (among others)
Believe what you want—we KNOW what we own: they did it before with Medistem (which was NOWHERE near monetization, and yet rose from pennies to $2+ PPS before the buyout) and we reasonably anticipate another landmark success with CELZ. Better board the train now, buddy...!
There are, in total, 9 patented IP holdings—the first to commercialize, CaverStem, is for ED. Also moving through the pipeline are Amniostem (one of whose intended application is for cancer-associated cachexia, as indicated in the recent release last week) and an anti-aging stem cell IP.
For my part, I’ve addressed the dilution myth. While the company HAS issued shares in order to finance its clinical operations—then results of which, having been hinted at by Dr. Gershman and others, will begin to be formally released ANY day now—I ask the following: why would the CFO (Dickerson) and CSO (Ichim), each of whom own 2.5M shares or less, be in favor of diluting the value of the golden goose (to say nothing of several other principals’ vested interests)? NOT LIKELY.
Trying SO bad to POP!